Brandes Investment Partners LP Sells 28,890 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Brandes Investment Partners LP trimmed its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) by 3.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 785,174 shares of the company’s stock after selling 28,890 shares during the quarter. Brandes Investment Partners LP owned approximately 0.91% of Pediatrix Medical Group worth $10,301,000 at the end of the most recent quarter.

Other large investors have also bought and sold shares of the company. Pacer Advisors Inc. bought a new stake in shares of Pediatrix Medical Group in the 4th quarter worth approximately $35,492,000. Weiss Asset Management LP boosted its position in shares of Pediatrix Medical Group by 50.5% in the 3rd quarter. Weiss Asset Management LP now owns 912,818 shares of the company’s stock worth $10,580,000 after purchasing an additional 306,143 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of Pediatrix Medical Group in the 4th quarter worth approximately $3,066,000. RBF Capital LLC bought a new stake in shares of Pediatrix Medical Group in the 3rd quarter worth approximately $1,695,000. Finally, Rubric Capital Management LP lifted its position in Pediatrix Medical Group by 1.5% in the 3rd quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company’s stock valued at $95,907,000 after acquiring an additional 125,000 shares in the last quarter. 97.71% of the stock is owned by institutional investors.

Pediatrix Medical Group Price Performance

Shares of MD opened at $13.71 on Friday. The firm has a market cap of $1.18 billion, a PE ratio of -11.42, a P/E/G ratio of 1.74 and a beta of 1.48. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The firm has a fifty day simple moving average of $14.16 and a two-hundred day simple moving average of $13.41. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.12. The business had revenue of $502.36 million during the quarter, compared to analyst estimates of $486.22 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. On average, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on MD shares. Truist Financial upped their price objective on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. Macquarie started coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price objective on the stock. UBS Group upped their price objective on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Mizuho upped their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Tuesday, November 19th. Finally, StockNews.com raised Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $17.08.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.